Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord serum therapy for corneal epithelial defect after diabetic vitrectomy
IRCT138903241180N15Phase 3Completed
- Sponsor
- Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences
- Start
- Dec 2009
- Modality
- Stem Cell Therapies → Cell Therapies, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of human umbilical cord blood serum in Corneal epithelial defect, sponsored by Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences. Started Dec 2009; status: completed.
02
Drugs
human umbilical cord blood serum
03
Conditions
Corneal epithelial defect
Beyond the preview
Go deeper on IRCT138903241180N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138903241180N15.